{"id":"W2284575850","doi":"10.1038/bjc.2016.21","title":"Circulating biomarkers and outcome from a randomised phase II trial of sunitinib vs everolimus for patients with metastatic renal cell carcinoma","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Novartis Pharmaceuticals Corporation","keywords":"Sunitinib; Everolimus; Medicine; Renal cell carcinoma; Internal medicine; Hazard ratio; Oncology; Biomarker; Urology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003667425,0.0009093501,0.002280772,0.0002704539,0.0003678907,0.001038205,0.0005042057,0.001181589,0.002931907],"category_scores_gemma":[0.003783212,0.0003616571,0.002385948,0.0003947929,0.0006305709,0.0007770227,0.0004421784,0.001604469,0.000338296],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001051761,"about_ca_system_score_gemma":0.001033367,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005142728,"about_ca_topic_score_gemma":0.001103719,"domain_scores_codex":[0.9981911,0.001067436,0.0001588922,0.000217526,0.0001850421,0.0001800704],"domain_scores_gemma":[0.9972451,0.0009512397,0.001046522,0.0001774922,0.0001190197,0.0004606743],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9715997,0.001228705,0.01298928,0.0003058946,0.002116758,0.00004223961,0.00004824412,0.0005081335,0.001475864,0.00003648115,0.0004102318,0.009238544],"study_design_scores_gemma":[0.7118952,0.1620991,0.1158154,0.00007879216,0.004523514,0.0002113482,0.00006238557,0.001419969,0.001909674,0.0003893027,0.001542275,0.00005290406],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959195,0.002168159,0.0001518587,0.0002182742,0.00007954061,0.0003986946,0.0006638819,0.00001389602,0.0003861482],"genre_scores_gemma":[0.9970589,0.0003960762,0.0001804202,0.0002243827,0.0001056327,0.0004931721,0.001116611,0.000004499003,0.0004203474],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003667425,"threshold_uncertainty_score":0.01939547,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02780223500681314,"score_gpt":0.2944268261468427,"score_spread":0.2666245911400296,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}